FI892005A - Molekulaera beten och ett foerfarande foer deras anvaendning. - Google Patents

Molekulaera beten och ett foerfarande foer deras anvaendning. Download PDF

Info

Publication number
FI892005A
FI892005A FI892005A FI892005A FI892005A FI 892005 A FI892005 A FI 892005A FI 892005 A FI892005 A FI 892005A FI 892005 A FI892005 A FI 892005A FI 892005 A FI892005 A FI 892005A
Authority
FI
Finland
Prior art keywords
receptor
pct
molekulaera
beten
foerfarande foer
Prior art date
Application number
FI892005A
Other languages
English (en)
Other versions
FI100169B (fi
FI892005A0 (fi
Inventor
Jonathan M Gershoni
Original Assignee
Jonathan M Gershoni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jonathan M Gershoni filed Critical Jonathan M Gershoni
Publication of FI892005A0 publication Critical patent/FI892005A0/fi
Publication of FI892005A publication Critical patent/FI892005A/fi
Application granted granted Critical
Publication of FI100169B publication Critical patent/FI100169B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Saccharide Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Paper (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polyamides (AREA)
FI892005A 1987-08-30 1989-04-27 Menetelmä molekulaarisen syötin valmistamiseksi FI100169B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL8368787 1987-08-30
IL8368787A IL83687A (en) 1987-08-30 1987-08-30 Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions
PCT/US1988/002991 WO1989001779A1 (en) 1987-08-30 1988-08-30 Molecular decoyants and methods of use thereof
US8802991 1988-08-30

Publications (3)

Publication Number Publication Date
FI892005A0 FI892005A0 (fi) 1989-04-27
FI892005A true FI892005A (fi) 1989-04-27
FI100169B FI100169B (fi) 1997-10-15

Family

ID=11058121

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892005A FI100169B (fi) 1987-08-30 1989-04-27 Menetelmä molekulaarisen syötin valmistamiseksi

Country Status (12)

Country Link
US (1) US5770572A (fi)
EP (1) EP0329778B1 (fi)
JP (1) JP2791074B2 (fi)
AT (1) ATE123224T1 (fi)
AU (1) AU2383988A (fi)
CA (1) CA1336489C (fi)
DE (1) DE3853910T2 (fi)
DK (1) DK175596B1 (fi)
FI (1) FI100169B (fi)
IL (1) IL83687A (fi)
NO (1) NO891787L (fi)
WO (1) WO1989001779A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02501192A (ja) * 1987-09-04 1990-04-26 バイオジェン インコーポレイテッド 可溶性ｔ４蛋白を製造するためのｄｎａ配列、組換ｄｎａ分子および方法
US5132402A (en) * 1987-11-25 1992-07-21 Agency Of Industrial Science And Technology Adsorbent, method for production thereof, and method for use thereof
EP0318240A3 (en) * 1987-11-25 1990-08-16 AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MINISTRY OF INTERNATIONAL TRADE & INDUSTRY Peptide, adsorbent, method for production thereof, and method for use thereof
US6919076B1 (en) * 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6908612B2 (en) 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US7311920B1 (en) 1999-10-08 2007-12-25 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
ITRM20010563A1 (it) * 2001-09-14 2003-03-14 Univ Siena Peptidi antigenici multipli come antidoti nell'intossicazione da veleno di serpente.
US8535672B2 (en) * 2002-04-04 2013-09-17 Yissum Research Development Of The Hebrew University Of Jerusalem Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
US20060094643A1 (en) * 2002-07-03 2006-05-04 Yuri Svirkin Compositions of hyaluronic acid and methods of use
JP4495776B1 (ja) 2009-07-30 2010-07-07 日本製薬株式会社 融合蛋白質
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
DK2691530T3 (en) 2011-06-10 2018-05-22 Univ Oregon Health & Science CMV GLYCOPROTEIN AND RECOMBINANT VECTORS
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US20150275231A1 (en) * 2014-03-31 2015-10-01 Mice With Horns, Llc Method of Preventing or Reducing Virus Transmission in Animals
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2570278B1 (fr) * 1984-09-14 1987-02-13 Pasteur Institut Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
US4761371A (en) * 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
DE3751751T2 (de) * 1986-08-21 1996-10-17 Univ Columbia Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
US5126433A (en) * 1986-08-21 1992-06-30 The Trustees Of Columbia University In The City Of New York Soluble forms of the t cell surface protein cd4

Also Published As

Publication number Publication date
US5770572A (en) 1998-06-23
FI100169B (fi) 1997-10-15
EP0329778A4 (en) 1990-12-27
DE3853910D1 (de) 1995-07-06
JPH02502538A (ja) 1990-08-16
DK211989A (da) 1989-06-28
DE3853910T2 (de) 1995-10-12
NO891787L (no) 1989-06-06
IL83687A0 (fi) 1988-01-31
WO1989001779A1 (en) 1989-03-09
IL83687A (en) 1995-03-30
EP0329778B1 (en) 1995-05-31
EP0329778A1 (en) 1989-08-30
DK175596B1 (da) 2004-12-13
CA1336489C (en) 1995-08-01
FI892005A0 (fi) 1989-04-27
ATE123224T1 (de) 1995-06-15
JP2791074B2 (ja) 1998-08-27
AU2383988A (en) 1989-03-31
NO891787D0 (no) 1989-04-28
DK211989D0 (da) 1989-05-01

Similar Documents

Publication Publication Date Title
FI892005A (fi) Molekulaera beten och ett foerfarande foer deras anvaendning.
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
PT781129E (pt) Preparacao farmaceutica contendo metformina e processo para a sua preparacao
GT199700095A (es) Derivados 6,5-heterobiciclicos sustituidos.
PT97363A (pt) Processo de preparacao de benzimidazoles substituidos e de composicoes farmaceuticas que os contem
ES2067022T3 (es) Complejos estabilizados de oxido nitrico y aminas primarias utiles como agentes cardiovasculares.
SE8103594L (sv) N-(vinblastin-23-oyl)aminosyraderivat
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
GT199700093A (es) Derivados 6,6-heterobiciclicos sustituidos.
PT100979A (pt) Epitopos de celula t dos alergenos principais de dermatophagoides (acaro do po domestico), peptidos modificados, sequencias de acidos nucleicos que os codificam, composicoes farmaceuticas que os contem e seu uso
PT98905A (pt) Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem
PT83961B (pt) Processo para a preparacao de derivados da pirazolina e de composicoes insecticidas e acaricidas que os contem
ES2117299T3 (es) Aparato para la inyeccion embrionaria temprana "in ovo".
FI834320A (fi) Peptidfoereningar.
DE69331758D1 (de) Fibrinogen-bildungsprotein
EP0173092A3 (en) Anti viral composition
DK384084A (da) Vaeksthormonfrigoerende peptider samt fremgangsmaade til behandling af pattedyr hermed
DK345889A (da) Anvendelse af 5-ht-3-receptorantagonist
ES8206447A1 (es) Procedimiento para preparar derivados de enterotoxina termoestable (st) de e. coli.
PT94625A (pt) Processo de preparacao de analogos de substituicao de peptidos magainina e de composicoes farmaceuticas que os contem
PT89311A (pt) Processo para a preparacao de novos aminoalcoxi-p-benzonitrilos substituidos utilizaveis como agentes antiarritmicos e de composicoes farmaceuticas que os contem
ES2058992T3 (es) Un procedimiento para la preparacion de polipeptido que estimula celulas t.
BR9808424A (pt) Composto, processos para a preparação do mesmo, para a preparação dos intermediários e para tratamento de um mamìfero, incluindo o ser humano, composição farmacêutica, e, uso de um composto.
PT99657A (pt) Processo para a preparacao de estereoisomeros de 7-{3-(1-amino-alquil)-1-pirrolidinil}-quinolonas e de composicoes farmaceuticas anti-bacterianas que os contem
BG30914A3 (en) Incecticide means and method for insects fighting

Legal Events

Date Code Title Description
FG Patent granted

Owner name: GERSHONI, JONATHAN M.

MA Patent expired